ARCHIVES

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Tests Early Phase Study To Hasten Drug Development

August 31, 2007

Bezwoda’s ’95 Phase II Study Entirely A Sham, Audit Finds.

April 27, 2001

In Brief: Jack McShulkis Dies Following Stroke; Congress Gives Final Approval to Appropriations Bill

October 28, 1983

In Brief: Less Hazardous Cigarette Only Hope To Reduce Smoking Health Problems, Carter Advisor Says

November 25, 1977

DCPC Advisor O Trial Of Cervical Lesion Management With HPV

June 3, 1994

NCI Begins Ovarian Cancer Trial To Build Blood Samples

October 28, 2005